AI 財演
@AIChoyYinTracked since Jul 2026
財經分析 財務報表研究 投資者教育.
Where the 83 observed tier members sit
Membership tiersLargest observed tier is CAD 0 Free. Tier totals include free-tier members and come from the Aug 20, 2026 public snapshot, so they do not reconcile to the paid-member total.
paid members unavailable
The chart only uses AI 財演's observed public history. Comparison peers are listed below, but comparable trend series are not available yet.
Where AI 財演 ranks
Creator comparisonsSemantic matches are not ready, so this fixed cohort uses the best available category, audience, pricing, and cadence evidence.
No comparable peer is available yet, so AI 財演's cohort rank cannot be calculated.Ranking data · includes stale rows| Rank | Creator and why included | Paid members | Gap vs AI 財演 | Freshness |
|---|---|---|---|---|
| Not ranked | Not measured | Reference | Aug 20, 2026Stale |
The rank uses the full fixed cohort. This table shows up to five creators around AI 財演; the coverage summary above still counts everyone.
Recent posts
What they publishPreviews available for 35 posts
Article Latest postPublic藥明康德(2359)毛利率暴升53.2%|TIDES多肽增44.3%|美客戶佔77%地緣風險|機會還是陷阱?必看🔍 藥明康德(2359)上半年業績重磅分析! 📊 核心數據亮點: ✅ 毛利率一鋪彈升至53.2% - 實力爆發還是短期煙花? ✅ 現金流升幅跑贏淨利潤 - 財務質素見真章 ✅ TIDES多肽業務勁升44.3% - 下一個增長引擎? ⚠️ 美國客戶佔比飆升至77% - 地緣政治風險警號 💡 本集重點拆解: 🎯 行業前景評估 🎯 產品競爭力分析 🎯 財務質素檢視 🎯 償債能力審視 🎯 建倉適配度判斷 藥明康德究竟係投資機會定係潛在陷阱?Bonnie & Felix 為你層層拆解,助你掌握關鍵入市訊號! 📺 想深入了解更多投資分析? 【免費】Patreon Channel: https://www.patreon.com/cw/AIChoyYin 【免費】AI財演 研究報告資料庫: https://aichoyin.com/ #AI財演 #投資分析 #股票投資 #入市訊號 #投資教育 #財經分析 #財務自由 #退休規劃 #2359 #藥明康德 #港股投資 #藍籌股 #香港投資
Yesterday at Aug 20 crawl 0 likes 0 commentsWork with this creator
Save, compare, or return to the Explore view you came from.